The AudioCure Family Grows Further

AudioCure has made exciting progress in its preclinical program by extending both its indication and compound pipelines in recent months. We are very pleased to announce that we have therefore extended our scientific team to continue pushing our preclinical...

The AudioCure Family is Growing

We are very happy to announce that we have expanded our team with further experts for formal preclinical and clinical development to propel our way into the clinical stage with our disease modifying lead compound AC102. AudioCure has gained the support of highly...